Science Explorer Back to mapMap
Discussion
Researcher · Eli Lilly (United States) · United States

David Raymond Ferry

David Raymond Ferry publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Surgery, on topics such as Colorectal Cancer Treatments and Studies, Gastric Cancer Management and Outcomes and Lung Cancer Treatments and Mutations.

OpenAlex
World rank
#85,793
of 7,710,434 ranked researchers
Rank in United States
#33,144
of 1,627,098
Works
155
Citations
17k
Citations per work
107.3
h-index
53
i10-index 103Top 3.2% in Oncology
David Raymond Ferry

What does David Raymond Ferry research?

David Raymond Ferry's work is mostly in Medicine (63%), Biochemistry, Genetics and Molecular Biology (14%).

Health Sciences: 98 works · 63.0% of their workMedicine: 98 works · 63.0% of their workOncology: 38 works · 24.4% of their workPulmonary and Respiratory Medicine: 31 works · 20.2% of their workSurgery: 19 works · 12.4% of their workCardiology and Cardiovascular Medicine: 9 works · 6.0% of their workEverything else: 36 works · 23.2% of their workLife Sciences: 21 works · 13.8% of their workBiochemistry, Genetics and Molecular Biology: 21 works · 13.8% of their workMolecular Biology: 16 works · 10.2% of their workCancer Research: 6 works · 3.6% of their workTHEIR WORKDavid RaymondFerry155works
Life Sciences14%Health Sciences63%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine9863.0%
  2. Everything else3623.2%
    1. Biochemistry, Genetics and Molecular Biology2113.8%
  1. 1Oncology24% of their works
  2. 2Pulmonary and Respiratory Medicine20% of their works
  3. 3Surgery12% of their works
  4. 4Molecular Biology10% of their works
  5. 5Cardiology and Cardiovascular Medicine6% of their works
  6. 6Cancer Research4% of their works

Research topics

Which keywords describe David Raymond Ferry's research?

The keywords of their largest research topics: Chemotherapy, Endoscopic Resection, Cetuximab, KRAS Mutations, Gastric Cancer, Molecular Characterization, EGFR Mutations and Esophageal Carcinoma.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Chemotherapy852 topics
  2. Endoscopic Resection682 topics
  3. Cetuximab431 topic
  4. KRAS Mutations431 topic
  5. Gastric Cancer421 topic
  6. Molecular Characterization421 topic
  7. EGFR Mutations261 topic
  8. Esophageal Carcinoma261 topic
  9. Preoperative Chemoradiotherapy261 topic
  10. Targeted Therapy261 topic
  11. Immune Checkpoint Blockade221 topic
  12. PD-1 and PD-L1221 topic
  13. Ion Channels171 topic
  14. Voltage-Gated Channels171 topic
  15. Imatinib Mesylate131 topic
  16. Sunitinib131 topic
  17. Neurotransmission111 topic
  18. Synaptic Plasticity111 topic

Where does David Raymond Ferry work?

David Raymond Ferry's main affiliation in the publication record is Eli Lilly (United States), United States.

How many publications and citations does David Raymond Ferry have?

OpenAlex counts 155 works and 16,627 citations for David Raymond Ferry, an h-index of 53, ranking #85,793 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about David Raymond Ferry. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.